Rockwell Medical Technologies (RMTI) Reports Q3 Loss of $0.10, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Rockwell Medical, Inc. Reports Third Quarter 2018 Financial Results
November 9, 2018 7:00 AM ESTWIXOM, Mich., Nov. 9, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company") today reported financial results for the third quarter ended September 30, 2018, and highlighted recent and upcoming corporate milestones.
Business Updates:
CMS Rule Clarifies U.S. Commercial Plans IV Triferic Expected to be Eligible for TDAPA Pricing Based on an analysis of CMS' November 1, 2018 final rule regarding the new Transitional Drug Add On Pricing Adjustment ("TDAPA") program, the Company believes that newly approved FDA therapies on or after January... More
